1.World Health Organization Model List of Essential Medicines 22nd List (2021) 2.Christopher S. Wilcox. Antihypertensive and Renal Mechanisms of SGLT2 (Sodium-Glucose Linked Transporter 2) Inhibitors. Hypertension. 2020 Mar 2: 1-8. 3.王建平,朱巧林.钠-葡萄糖协同转运蛋白2抑制剂与糖尿病心血管并发...
[20].Tikkanen, I., et al., Empagliflozin reduces blood pressure in patients with type 2 diabetes and hypertension. Diabetes Care, 2015. 38(3): p. 420-8. [21].Clar, C., et al., Systematic review of SGLT-2 receptor inhibitors in dual or triple therapy in type 2 diabetes. BMJ Open...
【摘要】钠-葡萄糖协同转运蛋白2(SGLT2)抑制剂通过增加肾脏葡萄糖的排出量而改善糖尿病患者的高血糖状态,同时可减轻体重,对胰岛素敏感性和胰岛素分泌功能具有一定的保护作用。因此,SGLT2抑制剂治疗糖尿病已经成为国内外新兴起的一个研究热点。 【关键词】钠-葡萄糖协同转运蛋白2抑制剂糖尿病血糖 钠-葡萄糖协同转运蛋...
[12]Sinha B, Ghosal S. A Meta-Analysis of the Effect of Sodium Glucose Cotransporter-2 Inhibitors on Metabolic Parameters in Patients With Polycystic Ovary Syndrome. Front Endocrinol (Lausanne). 2022 Feb 21;13:830401. doi: 10.3389/fendo.2022.830401. PMID: 35265039; PMCID: PMC8900375. [13]Hee...
[8] FDA Drug Safety Communication. FDA revises labels of SGLT2 inhibitors for diabetes to include warnings about too much acid in the blood and serious urinary tract infections. 2018. [9] Geerlings S, Fonseca V, Castro-Diaz D, List J, Parikh S. Genital and urinary tract infections in ...
第二型糖尿病新治疗药物-选择性SGLT2抑制剂-cgmhorgtw.PDF, 總編 :鄧新棠 主編 :李炳鈺 發行所 :林口、高雄、基隆 、台北、 桃園 、雲林、嘉義 ‧長庚紀念醫院 藥劑部 一百零二年十二月十五日出版 第二型糖尿病新治療藥物 選擇性- SGLT2 抑制劑 甘財源
sensitivity and insulin secretion function,as well as reduce weight.Therefore,SGLT2 inhibitors has become the domestic and foreign new emerged as a research hotspot. 【Key words】 sodium glucose co-transporters 2 inhibitors diabetes glucose 医药前沿 319 综述 2012年12月 谷氨酸是哺乳动物及人类中枢神经...
降糖新药-SGLT2抑制剂.doc,精品论文 参考文献 降糖新药-SGLT2抑制剂 崔志梅(通讯作者) 杨宏杰(上海中医药大学附属中西医结合岳阳医院内分泌科 200437) 【摘要】 钠-葡萄糖协同转运蛋白2(SGLT2)抑制剂通过增加肾脏葡萄糖的排出量而改善糖尿病患者的高血糖状态,同时可减
AHA: SGLT2 inhibitors, GLP-1 receptor agonists offer cardiorenal protection Trials of SGLT2 inhibitors and GLP-1 receptor agonists, typically treatments for type 2 diabetes, have demonstrated potential CV and kidney benefits , according to a scientific statement from the American Heart Association. ...
The Impact of SGLT2 Inhibitors on Cardiovascular Outcomes in Patients With Heart Failure With Preserved Ejection Fraction Review 作者:Pinner, Nathan A.;Starr, Jessica A. Objective: To evaluate the role of sodium-glucose cotransporter-2 (SGLT2) inhibitors in patients with heart failure with preserved...